Parina Aggarwal, MD
Sleep Medicine · Alpharetta, GANPI 1346443652
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,937 of the $2,233 with a category attached, or 86.8%. 14 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 36.6% of the total. 2025 is the largest year on record at $756, 5.8 times the $131 reported in 2019. That places this record below the midpoint for sleep medicine clinicians in GA, where the typical reported total is $2,223.
Across 65 payments — averaging $34.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$816
- Harmony Biosciences LLC$631
- Idorsia Pharmaceuticals US Inc$196
- Avadel CNS Pharmaceuticals, LLC$195
- Jazz Pharmaceuticals Inc.$93
- UCB, Inc.$51
- plus $250 from 8 others
What the payments were for
- Consulting fees$1507%
- Food & beverage$1,93787%
- Education$1457%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,233 in reported general payments places this provider in the 50th percentile of 50 sleep medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XywavSodium,calcium,mag,pot Oxybate | 11 | $211,381 |
| Adderall XrDextroamphetamine/Amphetamine | 24 | $4,884 |
| Eszopiclone | 11 | $316 |
| Gabapentin | 22 | $249 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 11 | $216 |
| Zolpidem Tartrate | 22 | $96 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Alpharetta
- Murad AssaadAtlanta$139K
- Nancy CollopAtlanta$28K
- Scott LeibowitzAtlanta$22K
- Anuj ChandraTrenton$20K
- Chantale BransonAtlanta$17K
- Melissa RhodesCartersville$14K
- James DalySavannah$12K
- Romy HoqueAtlanta$10K
- Naseer HumayunDalton$7K
- Praveen RastogiStockbridge$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.